---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-258115"
form_type: "8-K"
ticker: "ALGS"
cik: "0001799448"
company_name: "Aligos Therapeutics, Inc."
filed_at: "2023-10-18T23:59:59+00:00"
generated_at: "2026-06-09T21:55:05.260043+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Aligos settles Janssen lawsuit; dismisses counterclaims, releases all parties

## Summary
- Settlement agreement entered Oct 16, 2023 with Janssen Biotech resolving breach of contract and tortious interference claims.
- Janssen dismisses action and releases Aligos, CEO Lawrence Blatt, and President Leonid Beigelman from all claims.
- Aligos dismisses counterclaims for unfair competition and promissory fraud and releases Janssen.
- No admission of liability or financial terms of settlement disclosed in the filing.
- Litigation involved intellectual property ownership and claims against top executives.

## SEC filing metadata
- accession: 0001193125-23-258115
- form_type: 8-K
- ticker: ALGS
- cik: 0001799448
- company_name: Aligos Therapeutics, Inc.
- filed_at: 2023-10-18T23:59:59+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799448/000119312523258115/0001193125-23-258115-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799448/000119312523258115/d562095d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-258115
- JSON: https://secwatch.observer/filing/0001193125-23-258115.json
- Plain text: https://secwatch.observer/filing/0001193125-23-258115.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.